About this trial
Considering the high prevalence of cardiovascular disease in Turner syndrome patients, noninvasive cardiac imaging is crucial for diagnosis and follow-up. From the review of the literature, it was evident that the imaging techniques used involved the evaluation of only the thoracic findings, in particular the heart and the thoracic aorta, while no data are currently available on the distal abdominal aorta or iliac arteries, since ultrasound and MRI are interrupted at the diaphragmatic level.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
confirmed diagnosis of Turner Syndrome
patients underwent angioMR 1.5 T
age > 18 years
Disqualifiers
None
Trial population
cohort of patients with Turner syndrome \> 18 years
Trial design
Cohort
Retrospective
Treatments tested in this trial
imaging
Diagnostic testcardiac angioMR
Treatment groups
Trial outcomes
Primary outcomes
Vascular and cardiac anomalies
description of the main cardiovascular anomalies found by MRI at the thoracic and abdominal level anomalies in terms of supernumeray arteries and/or veins and measurement of length and diameters of main vascular tracts (e.g. ascending, descending aorta, aortic arch, renal arteries...) or vascular congenital abnormalities
Sponsors and contacts
Click on the lead sponsor to view all of their trials.